Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
出版年份 2023 全文链接
标题
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-02-02
DOI
10.1007/s00535-023-01963-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
- (2022) Yuki Tahata et al. JOURNAL OF GASTROENTEROLOGY
- Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?
- (2021) Walnei Fernandes Barbosa et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
- (2021) Toshifumi Tada et al. JOURNAL OF MEDICAL VIROLOGY
- Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
- (2021) Masanori Atsukawa et al. HEPATOLOGY RESEARCH
- Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection
- (2021) Eiichi Ogawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk‐stratification after variceal bleeding
- (2020) Vincenzo La Mura et al. HEPATOLOGY
- Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials
- (2020) Fred Poordad et al. JOURNAL OF VIRAL HEPATITIS
- Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients
- (2020) Kanako Kikukawa et al. Annals of Hepatology
- Persistence of clinically significant portal hypertension after eradication of HCV in patients with advanced cirrhosis
- (2020) Cristina Díez et al. CLINICAL INFECTIOUS DISEASES
- Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update
- (2020) HEPATOLOGY RESEARCH
- Impact of viral eradication by DAAs on the risk of HCC development, prognosis and portal hypertension in HCV‐related compensated cirrhosis patients
- (2020) Yuko Nagaoki et al. HEPATOLOGY RESEARCH
- Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
- (2020) Sabela Lens et al. JOURNAL OF HEPATOLOGY
- Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein
- (2020) Akira Yamamoto et al. GUT
- Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection
- (2020) Yoshinari Takaoka et al. HEPATOLOGY RESEARCH
- Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
- (2020) Yuki Tahata et al. JOURNAL OF GASTROENTEROLOGY
- Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
- (2020) Lisette A.P. Krassenburg et al. JOURNAL OF HEPATOLOGY
- Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis
- (2019) Scott A. McDonald et al. JOURNAL OF VIRAL HEPATITIS
- Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
- (2019) Shohei Tsuji et al. HEPATOLOGY RESEARCH
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
- (2018) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort
- (2018) R. Kozuka et al. JOURNAL OF VIRAL HEPATITIS
- Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C
- (2018) Masaru Enomoto et al. United European Gastroenterology Journal
- Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
- (2018) Tetsuo Takehara et al. JOURNAL OF GASTROENTEROLOGY
- Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis
- (2018) Kohei Kotani et al. MEDICINE
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
- (2017) Sabela Lens et al. GASTROENTEROLOGY
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
- (2017) Pierre Nahon et al. GASTROENTEROLOGY
- Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury
- (2017) Kei Morio et al. JOURNAL OF GASTROENTEROLOGY
- Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension
- (2017) N. Afdhal et al. JOURNAL OF VIRAL HEPATITIS
- Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
- (2016) P. Schwabl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
- (2016) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients
- (2016) Eisuke Miyaki et al. HEPATOLOGY RESEARCH
- Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
- (2016) Mattias Mandorfer et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
- (2012) Eirini I. Rigopoulou et al. AUTOIMMUNITY REVIEWS
- Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
- (2012) Thomas Reiberger et al. GUT
- 99mTc-GSA SPECT analysis was clinically useful to evaluate the effect of interferon in a patient with interferon non-responsive chronic hepatitis C
- (2011) Rika Ishii et al. ANNALS OF NUCLEAR MEDICINE
- Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis
- (2010) G. T. EVERSON et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started